Cargando…
Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill
Autores principales: | Deane, A, Fraser, R, Horowitz, M, Burgstad, C, Besanko, L, Finnis, M, Zaknic, A, Summers, M, Chapman, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084012/ http://dx.doi.org/10.1186/cc7290 |
Ejemplares similares
-
Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011) -
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
por: Deane, Adam M, et al.
Publicado: (2009) -
Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
por: Deane, Adam M, et al.
Publicado: (2011) -
The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
por: Lee, Michael Y., et al.
Publicado: (2013) -
The therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically ill
por: Deane, Adam M, et al.
Publicado: (2010)